Exec. VP and CLO of Ptc Therapeutics, Inc. (NASDAQ:PTCT), Boulding Mark Elliott, sells 772 shares worth $48,150
According to Ptc Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 05:05 PM, company Exec. VP and CLO, Boulding Mark Elliott disclosed selling 772 shares at a cost of $62.37. At the time of this transaction (Jan 05), this trade was worth $48,150 in total. As of Jan 05, Boulding Mark Elliott now owns 38,952 shares in total worth about $2,684,571.84.
For the last few recent trades made by Ptc Therapeutics, Inc. (NASDAQ:PTCT) Exec. VP and CLO, Boulding Mark Elliott, we have the following information:
- SEC Form 4 filing: Jul 07: Sold 30,625 shares at the rate of $55.12 per share. Total worth of this trade was $1,688,037. Total number of shares owned as of Jul 07 were 39,724
- SEC Form 4 filing: Jul 05: Sold 15,312 shares at the rate of $44.74 per share. Total worth of this trade was $685,097. Total number of shares owned as of Jul 05 were 29,524
- SEC Form 4 filing: Jun 28: Sold 77,575 shares at the rate of $45.00 per share. Total worth of this trade was $3,490,875. Total number of shares owned as of Jun 28 were 29,524
Posted by
George Daniels
on Thursday January 07 2021, 7:17 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
